CoChat

Elevated SIRT2 of serum exosomes is positively correlated with diagnosis of acute ischemic stroke patients

Open access

The DOI matches its Crossref record; 35 of the 39 references it cites were found in a registry or an index.

Abstract

Background: Silent Information Regulator 2 (SIRT2) protein inhibition has been shown to play a neuroprotective role in acute ischemic stroke (AIS) in mice. However, its role in AIS patients has not been fully understood. In this study, we aimed to analyze SIRT2 protein expression in serum exosomes of AIS and non-AIS patients, and evaluate its potential role in diagnosis and prognosis of AIS. Methods: Serum exosomes from 75 non-AIS subjects and 75 AIS patients were isolated. The SIRT2 protein levels in exosomes were analyzed using enzyme linked immunosorbent assay (ELISA). The National Institutes of Health Stroke Scale (NIHSS) was used to evaluate the severity of the disease. The modified Rankin Scale (mRS) was employed to assess the functional outcomes of the patients at 3-months following stroke onset. Results: The SIRT2 protein concentration of serum exosomes were higher in AIS patients than non-AIS patients (p < 0.001). Furthermore, the receiver operative characteristic curve (ROC) demonstrated that higher serum exosome SIRT2 could differentiate AIS patients from non-AIS patients with a sensitivity of 81.3% and a specificity of 75.3%. The area under the curve was 0.838 (95% CI: 0.775, 0.902). Additionally, higher SIRT2 concentration of serum exosomes were associated with NIHSS ≥ 4 (p < 0.001) and mRS ≥ 3 (p = 0.025) in AIS patients. The ROC analysis showed SIRT2 could discriminate stroke with NIHSS ≥ 4 from mild stroke (NIHSS < 4) with a sensitivity of 75.0% and a specificity of 69.6%. The area under the curve was 0.771 (95% CI: 0.661,0.881). Similarly, the test showed SIRT2 could differentiate between AIS patients with mRS ≥ 3 from those with mRS < 3 with a sensitivity of 78.3% and a specificity of 51.9%. The area under the curve was 0.663 (95% CI: 0.531,0.796). The logistic regression analysis revealed that SIRT2 concentration in serum exosomes can independently predict the diagnosis of AIS (odd ratio = 1.394, 95%CI 1.231–1.577, p < 0.001) and higher NIHSS scores (≥ 4) (odd ratio = 1.258, 95%CI 1.084–1.460, p = 0.002). However, it could not independently predict the prognosis of AIS (odd ratio = 1.065, 95%CI 0.983–1.154, p = 0.125). Conclusion: The elevation of SIRT2 in serum exosomes may be a valuable biomarker of AIS, which may be a potential diagnostic tool to facilitate decision making for AIS patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12883-023-03348-7

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 (A) Exosomes protein marker of CD63 and CD81 were detected in serum and serum exosomes by western blot. Full-length blots/gels are presented in the Supplementary Fig. 1. (B) Serum exosome SIRT2 concentration in control group (n = 75), AIS group (n = 75), NIHSS < 4 (n = 23), NIHSS ≥ 4 (n = 52), mRS < 3 (n = 52), and mRS ≥ 3(n = 23) group. (C) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and acute ischemic stroke. (D) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and NIHSS ≥ 4 acute ischemic stroke. (E) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and mRS ≥ 3 acute ischemic stroke. (F) The correlation between serum exosome SIRT2 concentration and mRS score of AIS by restricted cubic spline analysis. *p < 0.05 ***p < 0.001
Fig. 1 (A) Exosomes protein marker of CD63 and CD81 were detected in serum and serum exosomes by western blot. Full-length blots/gels are presented in the Supplementary Fig. 1. (B) Serum exosome SIRT2 concentration in control group (n = 75), AIS group (n = 75), NIHSS < 4 (n = 23), NIHSS ≥ 4 (n = 52), mRS < 3 (n = 52), and mRS ≥ 3(n = 23) group. (C) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and acute ischemic stroke. (D) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and NIHSS ≥ 4 acute ischemic stroke. (E) Receiver operating characteristic (ROC) curve of the relationship between Serum exosome SIRT2 concentration and mRS ≥ 3 acute ischemic stroke. (F) The correlation between serum exosome SIRT2 concentration and mRS score of AIS by restricted cubic spline analysis. *p < 0.05 ***p < 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 2

  1. Yuan S, Tang B, Zheng J, Larsson SC. Circulating lipoprotein lipids. Apolipoproteins and Ischemic Stroke. 2020;88(6):1229–36.
  2. Xie XQ, Zhang P, Tian B, Chen XQ. Downregulation of NAD-Dependent deacetylase SIRT2 protects mouse. Brain Against Ischemic Stroke. 2017;54(9):7251–61.

Cited by

See all 19

Metadata

Authors
Lu, W., Hou, D., Chen, X., Zhong, P., Liu, X., & Wu, D.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Tongji University (CN)
Corresponding author
  • Liu, Xueyuan
  • Wu, Danhong
Venue
BMC Neurology
Published
2023-09-08
Volume
23
Issue
1
Pages
321-321
ISSN
1471-2377 (ISSN-L)
OpenAlex
W4386544772
Cited by
17
References
39
Citations by year
2026: 6 · 2025: 3 · 2024: 6 · 2023: 2
FWCI
1.51
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the Talent Development Plan funded by Shanghai Fifth People’s Hospital, Fudan University (2020WYRCSG04)
  • Shanghai Committee of Science and Technology (201409004900 and 20S31904400)
  • Shanghai Minhang District Health and Family Planning Commission (2020MWDXK01)
  • Shanghai Fifth People’s Hospital Construction Project for Key Specialty (2020WYZDZK04)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
SIRT2, serum exosomes, acute ischemic stroke, stroke diagnosis, biomarkers, stroke severity, functional outcome, NIHSS, modified Rankin Scale, exosome isolation, SIRT2 inhibition, neuroprotection, stroke prognosis, blood-based biomarkers, ischemic penumbra, cerebral edema, cerebral infarction
MeSH terms
Cefdinir, Ischemic Stroke, Animals, United States, Stroke, Mice, Exosomes, Sirtuin 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Elevated SIRT2 of serum exosomes is positively correlated with diagnosis of acute ischemic stroke patients. https://app.cochat.ai/papers/10.1186/s12883-023-03348-7
The paper
Lu, W., Hou, D., Chen, X., Zhong, P., Liu, X., & Wu, D. (2023). Elevated SIRT2 of serum exosomes is positively correlated with diagnosis of acute ischemic stroke patients. BMC Neurology. https://doi.org/10.1186/s12883-023-03348-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.